Page last updated: 2024-11-05

3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole and Cancer of Prostate

3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole has been researched along with Cancer of Prostate in 3 studies

3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole: antineoplastic; activates platelet guanylate cyclase; a radiosensitizing agent and guanylate cyclase activator; structure in first source
lificiguat : A member of the class of indazoles that is 1H-indazole which is substituted by a benzyl group at position 1 and a 5-(hydroxymethyl)-2-furyl group at position 3. It is an activator of soluble guanylate cyclase and inhibits platelet aggregation.

Research Excerpts

ExcerptRelevanceReference
"In contrast, prostate cancer cells exposed to acute hypoxia (≤6 h) displayed increased motility, clonogenic survival, and invasive capacity."1.37Impact of hypoxia on the metastatic potential of human prostate cancer cells. ( Bae, K; Dai, Y; Siemann, DW, 2011)
"Hormone-refractory metastatic human prostate cancer PC-3 cells were selected for this study."1.33YC-1 suppresses constitutive nuclear factor-kappaB activation and induces apoptosis in human prostate cancer cells. ( Chang, YL; Guh, JH; Huang, YT; Kuo, SC; Lee, FY; Pan, SL; Teng, CM, 2005)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dai, Y1
Bae, K1
Siemann, DW1
Huang, YT2
Pan, SL2
Guh, JH2
Chang, YL1
Lee, FY2
Kuo, SC2
Teng, CM2
Sun, HL1
Liu, YN1
Huang, DY1

Other Studies

3 other studies available for 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole and Cancer of Prostate

ArticleYear
Impact of hypoxia on the metastatic potential of human prostate cancer cells.
    International journal of radiation oncology, biology, physics, 2011, Oct-01, Volume: 81, Issue:2

    Topics: Cell Death; Cell Hypoxia; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Enzyme

2011
YC-1 suppresses constitutive nuclear factor-kappaB activation and induces apoptosis in human prostate cancer cells.
    Molecular cancer therapeutics, 2005, Volume: 4, Issue:10

    Topics: Adenocarcinoma; Animals; Apoptosis; Caspase 3; Caspase Inhibitors; Caspases; Cell Cycle; Cell Line,

2005
YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt/NF-kappaB signaling to HIF-1alpha accumulation during hypoxia.
    Oncogene, 2007, Jun-07, Volume: 26, Issue:27

    Topics: Aryl Hydrocarbon Receptor Nuclear Translocator; Blotting, Western; Cell Hypoxia; Cell Line, Tumor; D

2007